A ZEISS Key Opinion Leader, Mr Hove is a respected international speaker with five invited engagements across seven cities in 2026: ZEISS China tour (Changsha, Shanghai, and Hangzhou, April ZEISS APAC User Meeting) RCOphth Annual Congress May Manchester ZEISS EMEA User Meeting (Istanbul) ZEISS Lausanne User Meeting (Lausanne) European Society of Cataract and Refractive Surgeons Annual Congress (ESCRS, London) Speak to Our Consultant-Led Team If you take a GLP-1 medication and have noticed any change in your vision, do not wait to have it checked
Rubino, MD, director of the Washington Center for Weight Management and Research in Arlington, Virginia, told Cardiology Today
As the respiratory organelle, mitochondria produces energy, Birsoy notes
As GLP-1 RAs become more prevalent in treating diabetes and patients with cardiovascular disease (CVD) or risk factors for CVD, clinicians will ultimately manage the practical aspects of patient selection, dosing, special considerations, and side effects of these medications
This categorization didnt constitute a formal regulation
Gevaren Ik heb geen diabetes, is het dan gevaarlijk om Ozempic te gebruiken